No Record Found
Sector
PharmaceuticalsOpen
₹104.46Prev. Close
₹104.25Turnover(Lac.)
₹50.12Day's High
₹104.89Day's Low
₹102.352 Week's High
₹12452 Week's Low
₹68.72Book Value
₹169.51Face Value
₹10Mkt Cap (₹ Cr.)
754.78P/E
34.57EPS
2.97Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | 
|---|---|---|---|---|
| Equity Capital | 142.84 | 67.21 | 59.81 | 59.81 | 
| Preference Capital | 14.2 | 14.2 | 0 | 0 | 
| Reserves | 1,021.24 | 730.94 | 615.54 | 572.75 | 
| Net Worth | 1,178.28 | 812.35 | 675.35 | 632.56 | 
| Minority Interest | 
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 | 
|---|---|---|---|---|
| Revenue | 856.57 | 751.83 | 731.29 | 693.71 | 
| yoy growth (%) | 13.93 | 2.8 | 5.41 | 8.6 | 
| Raw materials | -424.99 | -378.84 | -375.06 | -395.81 | 
| As % of sales | 49.61 | 50.38 | 51.28 | 57.05 | 
| Employee costs | -104.16 | -100.37 | -89.3 | -71.61 | 
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 | 
|---|---|---|---|---|
| Profit before tax | 16.11 | -19.56 | 30.51 | -50.85 | 
| Depreciation | -87.29 | -90.05 | -86.61 | -88.25 | 
| Tax paid | -20.51 | -1.22 | -10.95 | 16.46 | 
| Working capital | 24.4 | 224.01 | -12.39 | -206.93 | 
| Other operating items | 
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 | 
|---|---|---|---|---|
| Growth matrix (%) | ||||
| Revenue growth | 13.93 | 2.8 | 5.41 | 8.6 | 
| Op profit growth | 27.14 | 11.71 | 20.97 | -3.11 | 
| EBIT growth | 32.31 | 49.44 | 56.9 | -0.94 | 
| Net profit growth | -78.84 | -217.94 | -144.36 | -32.51 | 
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | 
|---|---|---|---|---|---|
| Gross Sales | 561.71 | 1,709.15 | 1,207.31 | 1,038.73 | 891.34 | 
| Excise Duty | 0 | 0 | 0 | 0 | 0 | 
| Net Sales | 561.71 | 1,709.15 | 1,207.31 | 1,038.73 | 891.34 | 
| Other Operating Income | 0 | 0 | 0 | 0 | 0 | 
| Other Income | 304.59 | 479.35 | 33.5 | 43.5 | 22.7 | 
| Company Name | LTP (₹) | P/E  (%) | Mkt.Cap  (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield  (%) | Sales Qtr  (₹.Cr) | Book Value (₹) | 
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,703.4 | 82.06 | 4,08,750.71 | 753.53 | 0.94 | 5,566.68 | 101.44 | 
| Divis Laboratories Ltd DIVISLAB | 6,655 | 75.61 | 1,76,633.5 | 557 | 0.45 | 2,357 | 561.08 | 
| Cipla Ltd CIPLA | 1,540.1 | 23.94 | 1,24,437.16 | 1,210.53 | 1.04 | 4,495.16 | 411.56 | 
| Torrent Pharmaceuticals Ltd TORNTPHARM | 3,602.4 | 61.3 | 1,21,865.35 | 551 | 0.17 | 2,567 | 224.34 | 
| Mankind Pharma Ltd MANKIND | 2,446.6 | 55.79 | 1,00,950.41 | 412.76 | 0 | 2,541.36 | 354.69 | 
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
N R Munjal
Joint Managing Director
Himanshu Jain
Company Sec. & Compli. Officer
Pradeep Verma
Executive Director
Rishav Mehta
Independent Director
S P Sharma
Independent Director
Neerja Chathley
Independent Director
Ashwani K Vig
Executive Director
Sahil Munjal
Independent Director
Rajendra Kumar Gupta
Independent Director
Param Bir Singh
SCO 850 Shivalik Enclave,
NAC Manimajra,
Chandigarh - 160101
Tel: 91-0172-5061850/2730920
Website: http://www.indswiftlabs.com
Email: investor@indswiftlabs.com, info@indswiftlabs.com
205/208,
Anarkali Market, Jhandewalan Extn,
New Delhi - 110055
Tel: 91-011-42541965/4254
Website: www.alankit.com
Email: info@alankit.com
Summary
Ind-Swift Laboratories Limited is a part of the Ind-Swift Group and is based at Chandigarh, India. The Company is one of the leading manufacturers of APIs catering to global and domestic formulators. ...
Read More
Reports by Ind-Swift Laboratories Ltd








 IIFL Customer Care Number
 IIFL Customer Care Number 
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000  / 7039-050-000
 IIFL Capital Services Support WhatsApp Number
 IIFL Capital Services Support WhatsApp Number
+91 9892691696


IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.